Fig. 3
Kaplan-Meier analysis comparing the overall survival of patients from the CMAB009 plus irinotecan arm to those in the sequential-CMAB009 arm. OS, overall survival; HR, hazard ratio; CI, confidence intervals
Fig. 3 | Cancer Communications